Evidence map›Paper›PMID 29782488›Full record

ArticlePLoS biology2018

Insight into small molecule binding to the neonatal Fc receptor by X-ray crystallography and 100 kHz magic-angle-spinning NMR.

Daniel Stöppler, Alex Macpherson, Susanne Smith-Penzel, Nicolas Basse, Fabien Lecomte, Hervé Deboves, Richard D Taylor, Tim Norman, John Porter, Lorna C Waters and 15 more

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Analysis of the structure and interactions of the SARS-CoV-2 ORF7b accessory protein.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Chemical reviews · 2022
    Review
  12. Article
  13. Article
  14. Article
  15. PDI Family Members as Guides for Client Folding and Assembly.International journal of molecular sciences · 2020
    Review
  16. Article
  17. Nucleotide Binding Modes in a Motor Protein Revealed byChembiochem : a European journal of chemical biology · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 9 institutions in 5 countries.

Daniel StöpplerLeibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany.ORCID 0000-0003-2540-1663
Alex MacphersonUCB Celltech, Slough, United Kingdom.
Susanne Smith-PenzelLaboratory of Physical Chemistry, ETH Zürich, Zürich, Switzerland.
Nicolas BasseSanofi, Strasbourg, France.
Fabien LecomteUCB Celltech, Slough, United Kingdom.
Hervé DebovesEvotec, Milton, United Kingdom.
Richard D TaylorUCB Celltech, Slough, United Kingdom.
Tim NormanUCB Celltech, Slough, United Kingdom.
John PorterMidatech Pharma Plc, Milton, United Kingdom.
Lorna C WatersLeicester Institute of Structural and Chemical Biology, University of Leicester, Leicester, United Kingdom.
Marta WestwoodUCB Celltech, Slough, United Kingdom.
Ben CossinsUCB Celltech, Slough, United Kingdom.
Katharine CainVertex, Milton, United Kingdom.
James WhiteUCB Celltech, Slough, United Kingdom.
Robert GriffinUCB Celltech, Slough, United Kingdom.
Christine ProsserUCB Celltech, Slough, United Kingdom.
Sebastian KelmUCB Celltech, Slough, United Kingdom.
Amy H SullivanBeryllium Discovery, Bedford, Massachusetts, United States of America.
David FoxBeryllium Discovery, Bedford, Massachusetts, United States of America.
Mark D CarrLeicester Institute of Structural and Chemical Biology, University of Leicester, Leicester, United Kingdom.
Alistair HenryUCB Celltech, Slough, United Kingdom.
Richard TaylorUCB Celltech, Slough, United Kingdom.
Beat H MeierLaboratory of Physical Chemistry, ETH Zürich, Zürich, Switzerland.
Hartmut OschkinatLeibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany.
Alastair D LawsonUCB Celltech, Slough, United Kingdom.
UCB Pharma (United Kingdom) · GBBeryllium (United States) · USETH Zurich · CHLeibniz-Forschungsinstitut für Molekulare Pharmakologie · DEUniversity of Leicester · GBEvotec (United Kingdom) · GBMidatech Pharma (United Kingdom) · GBSanofi (France) · FRVertex Pharmaceuticals (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aiming at the design of an allosteric modulator of the neonatal Fc receptor (FcRn)-Immunoglobulin G (IgG) interaction, we developed a new methodology including NMR fragment screening, X-ray crystallography, and magic-angle-spinning (MAS) NMR at 100 kHz after sedimentation, exploiting very fast spinning of the nondeuterated soluble 42 kDa receptor construct to obtain resolved proton-detected 2D and 3D NMR spectra. FcRn plays a crucial role in regulation of IgG and serum albumin catabolism. It is a clinically validated drug target for the treatment of autoimmune diseases caused by pathogenic antibodies via the inhibition of its interaction with IgG. We herein present the discovery of a small molecule that binds into a conserved cavity of the heterodimeric, extracellular domain composed of an α-chain and β2-microglobulin (β2m) (FcRnECD, 373 residues). X-ray crystallography was used alongside NMR at 100 kHz MAS with sedimented soluble protein to explore possibilities for refining the compound as an allosteric modulator. Proton-detected MAS NMR experiments on fully protonated [13C,15N]-labeled FcRnECD yielded ligand-induced chemical-shift perturbations (CSPs) for residues in the binding pocket and allosteric changes close to the interface of the two receptor heterodimers present in the asymmetric unit as well as potentially in the albumin interaction site. X-ray structures with and without ligand suggest the need for an optimized ligand to displace the α-chain with respect to β2m, both of which participate in the FcRnECD-IgG interaction site. Our investigation establishes a method to characterize structurally small molecule binding to nondeuterated large proteins by NMR, even in their glycosylated form, which may prove highly valuable for structure-based drug discovery campaigns.

Indexed as

Allosteric SiteCrystallography, X-RayHEK293 CellsHistocompatibility Antigens Class IHumansLigandsMagnetic Resonance SpectroscopyReceptors, FcFc receptor, neonatalHistocompatibility Antigens Class ILigandsReceptors, Fc

Identifiers

PMID29782488
PMCPMC5983862
OpenAlexW2803236733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.